Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.81 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.79 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.68 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.65 |
| ▸ | MAOB | P27338 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 4/20 | 0.62 |
| ▸ | RAB9A | P51151 | 3/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.62 |
| ▸ | NPC1 | O15118 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.62 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.62 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 4/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL79427 | 1.00 | KDM4E (0.81) | KDM4ECYP1A2HSD17B10ALDH1A1TRPM8 | |
| SCHEMBL4745286 | 1.00 | KDM4E (0.81) | KDM4ECYP1A2HSD17B10ALDH1A1TRPM8 | |
| SCHEMBL29644896 | 1.00 | KDM4E (0.81) | KDM4ECYP1A2HSD17B10ALDH1A1TRPM8 | |
| SCHEMBL7995904 | 1.00 | KDM4E (0.81) | KDM4ECYP1A2HSD17B10ALDH1A1TRPM8 | |
| SCHEMBL29690600 | 1.00 | KDM4E (0.81) | KDM4ECYP1A2HSD17B10ALDH1A1TRPM8 | |
| SCHEMBL4745288 | 1.00 | KDM4E (0.81) | KDM4ECYP1A2HSD17B10ALDH1A1TRPM8 | |
| Hydrochloric Acid SCHEMBL6821836 | 0.98 | KDM4E (0.79) | KDM4ECYP1A2HSD17B10ALDH1A1TRPM8 | |
| Hydrochloric Acid SCHEMBL27927566 | 0.98 | KDM4E (0.79) | KDM4ECYP1A2HSD17B10ALDH1A1TRPM8 | |
| Pyrrolidine SCHEMBL28573157 | 0.91 | KDM4E (0.68) | KDM4ECYP1A2HSD17B10ALDH1A1TRPM8 | |
| SCHEMBL10467644 | 0.91 | CYP1A2 (0.71) | KDM4ECYP1A2HSD17B10ALDH1A1TRPM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 660 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12593844-B2 | Method and compounds to induce plant tolerance against arthropod pests | VIB VZW (BE) | 2026-04-07 | — | — | US | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| US-20250213637-A1 | KAVA DERIVED THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF | KUALITY HERBCEUTICS LLC (US) | 2025-07-03 | — | — | US | claimed |
| US-20250163006-A1 | New Coolants, and Preparations Containing Same | SYMRISE AG (DE) | 2025-05-22 | — | — | US | claimed |
| WO-2025081932-A1 | RETINOL DERIVATIVE OR SALT THEREOF, AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳市护家科技有限公司 | 2025-04-24 | — | — | WO | claimed |
| CN-119841755-A | Retinol derivative or its salt, and preparation method and application thereof | 深圳市护家科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| US-20250066320-A1 | Active Ingredients with Sialagogue and Tingling/Fizzy Effect, and Preparations Containing Same | SYMRISE AG (DE) | 2025-02-27 | — | — | US | claimed |
| CN-112353791-B | Slip-derived therapeutic compounds and methods of use thereof | 夸利蒂赫布丘蒂克斯公司 | 2025-02-25 | — | — | CN | claimed |
| EP-4469439-A1 | NEW COOLANTS, AND PREPARATIONS CONTAINING SAME | Symrise AG (DE) | 2024-12-04 | — | — | EP | claimed |
| EP-4452941-A1 | ACTIVE INGREDIENTS WITH SIALAGOGUE AND TINGLING/FIZZY EFFECT, AND PREPARATIONS CONTAINING SAME | Symrise AG (DE) | 2024-10-30 | — | — | EP | claimed |
| JP-2002541233-A | — | — | 2002-12-03 | — | — | JP | claimed |
| CN-1354740-A | Pharmaceutical compounds | NICOX SA (FR) | 2002-06-19 | — | — | CN | claimed |
| EP-1192129-A2 | PHARMACEUTICAL COMPOUNDS | NICOX S.A. (FR) | 2002-04-03 | — | — | EP | claimed |
| EP-1169337-A2 | STEROID NITRATES FOR THE TREATMENT OF OXIDATIVE INJURY AND ENDOTHELIAL DYSFUNCTION | NICOX S.A. (FR) | 2002-01-09 | — | — | EP | claimed |
| EP-1169294-A2 | PHARMACEUTICAL COMPOUNDS | NICOX S.A. (FR) | 2002-01-09 | — | — | EP | claimed |
| WO-2000061549-A2 | PHARMACEUTICAL COMPOUNDS | NICOX S.A. (FR) | 2000-10-19 | — | — | WO | claimed |
| WO-2000061604-A2 | PHARMACEUTICAL COMPOUNDS | NICOX S.A. (FR) | 2000-10-19 | — | — | WO | claimed |
| WO-2000061537-A2 | PHARMACEUTICAL COMPOUNDS | NICOX S.A. (FR) | 2000-10-19 | — | — | WO | claimed |
| EP-0954596-A1 | ENHANCED PRODUCTION OF TAXANES BY CELL CULTURES OF $i(TAXUS) SPECIES | PHYTON, INC. (US) | 1999-11-10 | — | — | EP | claimed |
| WO-1997044476-A1 | ENHANCED PRODUCTION OF TAXANES BY CELL CULTURES OF TAXUS SPECIES | PHYTON, INC. (US) | 1997-11-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12593844-B2 | Method and compounds to induce plant tolerance against arthropod pests | HPD, PAH, P4HTM | KDM4E 329/4885CYP1A2 754/4885HSD17B10 681/4885 |
| US-20250066320-A1 | Active Ingredients with Sialagogue and Tingling/Fizzy Effect, and Preparations Containing Same | TAS2R5, TAS2R7, TAS2R8 | KDM4E 4202/4885CYP1A2 3463/4885HSD17B10 4026/4885 |
| US-20250213637-A1 | KAVA DERIVED THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF | KLK5, KLK4, KLK2 | KDM4E 90/4885CYP1A2 932/4885HSD17B10 591/4885 |
| US-20250163006-A1 | New Coolants, and Preparations Containing Same | TTR, TAS2R5, TAS2R50 | KDM4E 4049/4885CYP1A2 1923/4885HSD17B10 1631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.